Patients carrying inactivating mutations in the thyroid hormone (TH)-specific monocarboxylate transporter 8 (MCT8) show global developmental delays and a complex cluster of severe intellectual and motor disabilities (Allan-Herndon-Dudley syndrome (AHDS)) [1,2,3,4]. Here, SLC16A2 is linked to Allan-Herndon-Dudley syndrome.